Upregulation of tumor necrosis factor-α gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome

Journal of Clinical Investigation

Volumn 100, Issue 8, 1997, Pages 1969-1979

  Lay, Jong Ding ^b   Tsao, Chao Jung ^a   Chen, Jen Yang ^b   Kadin, Marshall E ^c   Su, Ih Jen ^a,b  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Epstein barr virus; Hemophagocytic syndrome; T NK cell lymphoma; Tumor necrosis factor

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1ALPHA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; B CELL LYMPHOMA; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE CONTROL; HEMOPHAGOCYTIC SYNDROME; HUMAN; HUMAN CELL; MACROPHAGE ACTIVATION; PATHOGENESIS; PHAGOCYTOSIS; PRIORITY JOURNAL; T CELL LYMPHOMA; T LYMPHOCYTE;

EID: 0030770948     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119728     Document Type: Article

References (47)

1. Risdall, R.J., R.W. McKenna, M.E. Nesbit, M. Kribit, H. Balfour, R. Simmons, and R.D. Brunning. 1979. Virus-associated hemophagocytic syndrome-A benign histiocytic proliferation distinct from malignant histiocytosis. Cancer. 44:993-1002.
2. Su, I.J., C.H. Wang, A.L. Cheng, and R.C. Chen. 1995 Hemophagocytic syndrome in Epstein-Barr virus-associated T-lymphoproliferative disorders. Disease spectrum, pathogenesis and management. Leuk. Lymphoma. 19:401-406.
3. Su, I.J., H.C. Hsieh, and C.Y. Lee. 1989. Histiocytic medullary reticulosis: a lethal form of primary EBV infection in young children in Taiwan. Lancet. 27:519.
4. Chen, R.L., I.J. Su, K.S. Lin, S.H. Lee, D.T. Lin, W.M. Chuu, K.S. Lin, L.M. Hung, and C.Y. Lee. 1991. Fulminant childhood hemophagocytic medullary reticulosis. Am. J. Clin. Pathol. 96:171-176.
5. Henter, J.L., G. Elinder, and A. Ost. 1991. The FHL study group of the histiocyte society diagnostic guidelines for hemophagocytic lymphohistiocytosis. Semin. Oncol. 18:29-33.
6. Simrell, C.R., J.B. Margolick, G.R. Crabtree, J. Cossman, A.S. Fauci, and E.S. Jaffe. 1985. Lymphokine-induced phagocytosis in angiocentric immunoproliferative lesions (AIL) and malignant lymphoma arising in AIL. Blood. 65: 1469-1476.
7. Ohga, S., A. Matsuzaki, M. Nishizaki, T. Nagashima, T. Kai, M. Suda, and K. Ueda. 1993. Inflammatory cytokines in virus-associated hemophagocytic syndrome: interferon gamma as a sensitive indicator of disease activity. Am. J. Pedi. Hema. Oncol. 15:291-298.
8. Henter, J.I., G. Elinder, O. Soder, M. Hansson, B. Anderson, and U. Anderson. 1991. Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood. 78:2918-2922.
9. Temeles, D.S., H.E. McGrath, E.L.W. Kitter, R.K. Shadduck, V.K. Kister, R.B. Crittenden, B.L. Turner, and P.J. Quensenberry. 1993. Cytokine expression from bone marrow derived macrophages. Exp. Hematol. (NY). 21:388-393.
10. Foss, H.D., H. Herbst, M. Hummel, I. Araujo, U. Latza, C. Rancso, F. Dallenbach, and H. Stein. 1994. Pattern of cytokine gene expression in infectious mononucleosis. Blood. 83:707-712.
11. Imashuku, S., S. Hibi, F. Fujiwara, S. Ikushima, and S. Toso. 1994. Haemophagocytotic lymphohistiocytosis, interferon-gamma-naemia and Epstein-Barr virus involvement. Brit. J. Haematol. 88:656-658.
12. Ishii, E., S. Ohga, T. Aoki, S. Yamada, M. Sako, H. Tasaka, A. Kuwano, M. Sasaki, Y. Tsunematsu, and K. Ueda. 1991. Prognosis of children with virus-associated hemophagocytic syndrome and malignant histiocytosis: correlation with levels of serum interleukin-1 and tumor necrosis factor. Acta Haematol. (Basel). 85:93-99.
13. Ng, C.S., J.K.C. Chan, P.N.M. Cheng, and S.C. Szeto. 1986. Nasal T-cell lymphoma associated with hemophagocytic syndrome. Cancer. 58:67-71.
14. Craig, F.E., C.N. Clare, J.L. Sklar, and P.M. Banks. 1992. T cell lymphoma and the virus-associated hemophagocytic syndrome. Am. J. Clin. Pathol. 97:189-194.
15. Falini, B., S. Pileri, I. de Solas, M.F. Martell, D.Y. Mason, G. Delsol. K.C. Gatter, and M. Fagioli. 1990. Peripheral T-cell lymphoma associated with hemophagocytic syndrome. Blood. 75:434-444.
16. Su, I.J., Y.H. Hsu, M.T. Lin, A.L. Cheng, C.W. Wang, and L.M. Weiss. 1993. Epstein-Barr virus-containing T cell lymphoma presents with hemophagocytic syndrome mimicking malignant histiocytosis. Cancer. 72:2019-2027.
17. Su, I.J., H.C. Hsieh, K.H. Lin, W.C. Uen, C.L. Kao, C.L. Chen, A.L. Cheng, M.E. Kadin, and J.Y. Chen. 1991. Aggressive peripheral T cell lymphoma containing Epstein-Barr virus DNA: a clinicopathological and molecular analysis. Blood. 77:799-808.
18. Su, I.J., R.L. Chen, D.T. Lin, K.S. Lin, and C.C. Chen. 1994. Epstein-Barr virus (EBV) infects T lymphocytes in childhood EBV-associated hemophagocytic syndrome in Taiwan. Am. J. Pathol. 144:1219-1225.
19. Tsoukas, C.D., and J.D. Lambris. 1993. Expression of EBV/C3d receptors on T cells: biological significance. Immunol. Today. 14:56-59.
20. Watry, D., J.A. Hedrick, S. Siervo, G. Rhodes, J.J. Lamberti, J.D. Lambris, and C.D. Tsoukas. 1991. Infection of human thymocytes by Epstein-Barr virus. J. Exp. Med. 173:971-980.
21. Kawaguchi, H., T. Kiyashita, H. Herbst, G. Niedobitek, M. Asada, M. Tsuchida, R. Hanada, A. Kinoshita, M. Sakurai, N. Kobayashi, and S. Mizutani. 1993. Epstein-Barr virus-infected T lymphocytes in Epstein-Barr virus-associated hemophagocytic syndrome. J. Clin. Invest. 92:1444-1450.
22. Jaffe, E.S., J.K.C. Chan, I.J. Su, G. Frizzera, S. Mori, A.C. Feller, and C.S. Ho. 1996. Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas. Definitions, differential diagnosis, and epidemiology. Am. J. Surg. Pathol. 20:103-111.
23. Heies, M.T., and H.W. Virgin IV. 1995. The T-cell-independent role of gamma-interferon and tumor necrosis factor alpha in macrophage activation during murine cytomegalovirus and herpes simplex virus infection. J. Virol. 69: 904-909.
24. Geist, L.J., M.M. Monick, M.F. Stinski, and G.W. Hunninghake. 1994. The immediate early genes of human cytomegalovirus upregulate tumor necrosis factor gene expression. J. Clin. Invest. 93:474-478.
25. Baranji, K., L. Baranyi, T. Yoshida, N. Okada, and H. Okada. 1994. A low molecular weight phagocytosis-inhibitory factor obtained from human erythrocyte membranes specifically down-regulates Mac-1 activity on tetradecanoyl phorbol acetate-stimulated monocytic cell lines in a Ca2+-dependent manner. J. Immunol. 153:1724-1735.
26. Kao, Y.F., T.Y. Hsu, M.Y. Liu, J.Y. Chen, and C.S. Yang. 1993. Infection of CR2-expressing human epithelial cells with Epstein-Barr virus. In Epstein-Barr Virus and Associated Disease. T. Tursz, J.S. Pagano, D.V. Ablashi, G. de The, and G.R. Pearson, editors. John Libbey Eurotext/John Libbey Co. Ltd., Montrouge, London. 177-182.
27. Gaffey, M.J., H.F. Frierson, L.J. Medeiros, and L.M. Weiss. 1993. The relationship of Epstein-Barr virus to infection-related (sporadic) and familial hemophagocytosis: an in situ hybridization study. Hum. Pathol. 24:657-667.
28. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
29. Yao, M., A.L. Cheng, I.J. Su, M.T. Lin, W.C. Uen, H.F. Tien, C.H. Wang, and Y.C. Chen. 1994. Clinicopathologic spectrum of hemophagocytic syndrome in Epstein-Barr virus-associated peripheral T cell lymphoma. Br. J. Haematol. 87:535-543.
30. Wong, K.F., J.K.C. Chan, E.S.F. Lo, and C.S.C. Wong. 1996. A study of the possible etiologic association of Epstein-Barr virus with reactive hemophagocytic syndrome in Hong Kong Chinese. Hum. Pathol 27:1239-1242.
31. Akashi, K., S. Hayashi, H. Gondo, S.I. Mizuno, M. Harada, K. Tamura, K. Yamasaki, T. Shibura, N. Uike, T. Okamura, et al. 1994. Involvement of interferon-gamma and macrophage-stimulating factor in pathogenesis of hemophagocytic lymphohistiocytosis in adults. Br. J. Haematol. 87:243-250.
32. Foss, H.D., I. Anagnostopoulos, H. Herbst, K. Ziemann, M. Hummel, and H. Stein. 1995. Patterns of cytokine gene expression in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type. Blood. 85:2862-2869.
33. Rusten, L.S., E.B. Smeland, F.W. Jacobsen, E. Lien, W. Lesslauer, H. Loetscher, C.M. Dubois, and E.W. Facobsen. 1994. Tumor necrosis factor-alpha inhibits stem cell factor-induced proliferation of human bone marrow progenitor cells in vitro. J. Clin. Invest. 94:165-172.
34. Mizuhara, H., E. O'Neill, N. Seki, T. Ogawa, C. Kusunoki, K. Otsuka, S. Satoh, M. Niwa, H. Senoh, and H. Fujiwara. 1994. T cell activation-associated hepatic injury: mediation by tumor necrosis factor and protection by interleukin-6. J. Exp. Med. 179:1529-1537.
35. Feingold, K., M. Soued, I. Staprans, L.A. Gavin, M.E. Donahue, B.J. Huang, A.J. Moser, R. Gulli, and C. Grunfeld. 1989. Effect of tumor necrosis factor (TNF) on lipid metabolism in the diabetic rat: evidence that inhibition of adipose tissue lipoprotein lipase activity is not required for TNF-induced hyperlipidemia. J. Clin. Invest. 83:1116-1121.
36. Oliff, A., D. Defeo-Jones, M. Boyer, D. Martinez, D. Kiefer, G. Vuocolo, A. Wolfe, and S.H. Socher. 1987. Tumors secreting human TNF/cachectin induce cachexia in mice. Cell. 50:555-563.
37. Gosselin, J., L. Flamand, M. D'Addario, J. Hiscott, and J. Menezes. 1992. Infection of peripheral blood mononuclear cells by herpes simplex and Epstein-Barr viruses: differential induction of interleukin 6 and tumor necrosis factor-α. J. Clin. Invest. 89:1849-1856.
38. Probert, L., J. Keffer, P. Corbella, H. Cazlaris, E. Patsavoudi, S. Stephens, E. Kaslaris, D. Kioussis, and G. Kollias. 1993. Wasting, ischemia and lymphoid abnormalities in mice expressing T cell targeted human tumor necrosis factor trangenes. J. Immunol. 151:1894-1906.
39. Kieff, E., and D. Leibowitz. 1991. The Epstein-Barr virus and its replication. In Fundamental Virology. B.N. Fields and D.M. Knipe, editors. Raven Press Ltd., New York. 168-194.
40. Wang, F., C.D. Gregory, M. Rowe, A.B. Rickinson, D. Wang, M. Birkenbach, H. Kikutani, T. Kishimoto, and E. Kieff. 1987. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B cell activation antigen CD23. Proc. Natl. Acad. Sci. USA. 84:3452-3456.
41. Peng, M., and E. Lundgren. 1993. Transient expression of the Epstein-Barr virus LMP1 gene in B-cell chronic lymphocytic leukemia cells, T cells, and hematopoietic cell lines: cell-type-independent-induction of CD23, CD21, and ICAM-1. Leukemia (Baltimore). 7:104-112.
42. Huen, D.S., S.A. Henderson, D. Croom-Carter, and M. Rowe. 1995. The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF(κB and cell surface phenotype via two effector regions in its carboxyl-terminal cytoplasmic domain. Oncogene. 10:549-560.
43. Mosialos, G., M. Birkenbach, R. Yalamanchili, T. VanArsdale, C. Ware, and E. Kieff. 1995. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell. 80:389-399.
44. Ambruso, D.R., T. Hays, W.F. Zwartjes, D.G. Tubergen, and B.E. Favara. 1980. Successful treatment of lymphohistiocytosis with epipidophyllotoxin VP-16. Cancer. 45:2516-2520.
45. Brown, R.E., W.P. Bowman, C.A. D'Cruz, T.E. Pick, and J.E. Champion. 1987. Endoperoxidation, hyperprostaglandinemia, and hyperlipidemia in a case of erythrophagocytotic lymphohistiocytosis. Reversal with VP-16 and indomethacin. Cancer. 60:2388-2393.
46. Nydegger, U.E. 1992. Intravenous immunoglobulin in combination with other prophylactic and therapeutic measures. Transfusion (Phila.). 32:72-82.
47. Chen, R.L., K.H. Lin, D.T. Lin, I.J. Su, L.M. Huang, P.I. Lee, K.H. Hseih, K.S. Lin, and C.Y. Lee. 1995. Immunomodulation treatment for childhood virus-associated hemophagocytic lymphohistiocytosis. Br. J. Haematol. 89:282-290.